A  ||| S:0 E:2 ||| DT
CASE  ||| S:2 E:7 ||| NN
OF  ||| S:7 E:10 ||| IN
ASCENDING  ||| S:10 E:20 ||| NNP
COLON  ||| S:20 E:26 ||| NNP
CANCER  ||| S:26 E:33 ||| NNP
RECURRENCE  ||| S:33 E:44 ||| NNP
WITH  ||| S:44 E:49 ||| NNP
INTRALUMINAL  ||| S:49 E:62 ||| NNP
URETERAL  ||| S:62 E:71 ||| NNP
DISSEMINATION  ||| S:71 E:85 ||| NNP
MIMICKING  ||| S:85 E:95 ||| NNP
PRIMARY  ||| S:95 E:103 ||| NNP
URETERAL  ||| S:103 E:112 ||| NNP
CANCER ||| S:112 E:118 ||| NNP
,  ||| S:118 E:120 ||| ,
DETECTED  ||| S:120 E:129 ||| NNP
DURING  ||| S:129 E:136 ||| NNP
INVESTIGATION  ||| S:136 E:150 ||| NNP
FOR  ||| S:150 E:154 ||| IN
FEVER  ||| S:154 E:160 ||| NNP
A  ||| S:160 E:162 ||| NNP
69-year-old  ||| S:162 E:174 ||| NNP
woman  ||| S:174 E:180 ||| NN
visited  ||| S:180 E:188 ||| VBD
our  ||| S:188 E:192 ||| PRP$
hospital  ||| S:192 E:201 ||| NN
with  ||| S:201 E:206 ||| IN
a  ||| S:206 E:208 ||| DT
chief  ||| S:208 E:214 ||| JJ
complaint  ||| S:214 E:224 ||| NN
of  ||| S:224 E:227 ||| IN
fever ||| S:227 E:232 ||| NN
.  ||| S:232 E:234 ||| .
Five  ||| S:234 E:239 ||| CD
years  ||| S:239 E:245 ||| NNS
ago ||| S:245 E:248 ||| RB
,  ||| S:248 E:250 ||| ,
she  ||| S:250 E:254 ||| PRP
was  ||| S:254 E:258 ||| VBD
diagnosed  ||| S:258 E:268 ||| VBN
as  ||| S:268 E:271 ||| IN
ascending  ||| S:271 E:281 ||| VBG
colon  ||| S:281 E:287 ||| NN
cancer  ||| S:287 E:294 ||| NN
and  ||| S:294 E:298 ||| CC
received  ||| S:298 E:307 ||| VBD
right  ||| S:307 E:313 ||| RB
hemi-colectomy ||| S:313 E:327 ||| JJ
.  ||| S:327 E:329 ||| .
One  ||| S:329 E:333 ||| CD
year  ||| S:333 E:338 ||| NN
later ||| S:338 E:343 ||| RB
,  ||| S:343 E:345 ||| ,
local  ||| S:345 E:351 ||| JJ
recurrence  ||| S:351 E:362 ||| NN
with  ||| S:362 E:367 ||| IN
right  ||| S:367 E:373 ||| JJ
hydronephrosis  ||| S:373 E:388 ||| NN
was  ||| S:388 E:392 ||| VBD
detected ||| S:392 E:400 ||| VBN
,  ||| S:400 E:402 ||| ,
and  ||| S:402 E:406 ||| CC
she  ||| S:406 E:410 ||| PRP
received  ||| S:410 E:419 ||| VBD
chemotherapy  ||| S:419 E:432 ||| CD
-4  ||| S:432 E:435 ||| CD
cycles  ||| S:435 E:442 ||| NNS
of  ||| S:442 E:445 ||| IN
modified  ||| S:445 E:454 ||| JJ
fluorouracil ||| S:454 E:466 ||| NN
,  ||| S:466 E:468 ||| ,
leucovorin ||| S:468 E:478 ||| NN
,  ||| S:478 E:480 ||| ,
and  ||| S:480 E:484 ||| CC
oxaliplatin  ||| S:484 E:496 ||| NNS
( ||| S:496 E:497 ||| -LRB-
mFOLFOX6 ||| S:497 E:505 ||| NNP
)  ||| S:505 E:507 ||| -RRB-
plus  ||| S:507 E:512 ||| CC
bevacizumab ||| S:512 E:523 ||| NN
,  ||| S:523 E:525 ||| ,
and  ||| S:525 E:529 ||| CC
12  ||| S:529 E:532 ||| CD
cycles  ||| S:532 E:539 ||| NNS
of  ||| S:539 E:542 ||| IN
fluorouracil ||| S:542 E:554 ||| NN
,  ||| S:554 E:556 ||| ,
leucovorin ||| S:556 E:566 ||| NN
,  ||| S:566 E:568 ||| ,
and  ||| S:568 E:572 ||| CC
irinotecan  ||| S:572 E:583 ||| NNS
( ||| S:583 E:584 ||| -LRB-
FOLFIRI ||| S:584 E:591 ||| NNP
)  ||| S:591 E:593 ||| -RRB-
plus  ||| S:593 E:598 ||| CC
bevacizumab-  ||| S:598 E:611 ||| JJ
for  ||| S:611 E:615 ||| IN
two  ||| S:615 E:619 ||| CD
years ||| S:619 E:624 ||| NNS
.  ||| S:624 E:626 ||| .
Local  ||| S:626 E:632 ||| JJ
recurrence  ||| S:632 E:643 ||| NN
and  ||| S:643 E:647 ||| CC
right  ||| S:647 E:653 ||| JJ
hydronephrosis  ||| S:653 E:668 ||| NN
disappeared  ||| S:668 E:680 ||| VBD
on  ||| S:680 E:683 ||| IN
positron  ||| S:683 E:692 ||| JJ
emission  ||| S:692 E:701 ||| NN
tomography  ||| S:701 E:712 ||| NNS
performed  ||| S:712 E:722 ||| VBD
4  ||| S:722 E:724 ||| CD
years  ||| S:724 E:730 ||| NNS
postoperatively ||| S:730 E:745 ||| VBD
.  ||| S:745 E:747 ||| .
This  ||| S:747 E:752 ||| DT
time ||| S:752 E:756 ||| NN
,  ||| S:756 E:758 ||| ,
abdominal  ||| S:758 E:768 ||| JJ
computed  ||| S:768 E:777 ||| JJ
tomography  ||| S:777 E:788 ||| NN
for  ||| S:788 E:792 ||| IN
investigation  ||| S:792 E:806 ||| NN
of  ||| S:806 E:809 ||| IN
fever  ||| S:809 E:815 ||| NN
showed  ||| S:815 E:822 ||| VBD
a  ||| S:822 E:824 ||| DT
relapse  ||| S:824 E:832 ||| NN
of  ||| S:832 E:835 ||| IN
right  ||| S:835 E:841 ||| JJ
hydronephrosis  ||| S:841 E:856 ||| NN
and  ||| S:856 E:860 ||| CC
pyonephrosis ||| S:860 E:872 ||| NN
.  ||| S:872 E:874 ||| .
Cystoscopy  ||| S:874 E:885 ||| NNP
revealed  ||| S:885 E:894 ||| VBD
non-papillary  ||| S:894 E:908 ||| JJ
tumor  ||| S:908 E:914 ||| NN
from  ||| S:914 E:919 ||| IN
the  ||| S:919 E:923 ||| DT
right  ||| S:923 E:929 ||| JJ
ureteral  ||| S:929 E:938 ||| JJ
orifice ||| S:938 E:945 ||| NN
.  ||| S:945 E:947 ||| .
Pelvic  ||| S:947 E:954 ||| JJ
magnetic  ||| S:954 E:963 ||| JJ
resonance  ||| S:963 E:973 ||| NN
imaging  ||| S:973 E:981 ||| NN
showed  ||| S:981 E:988 ||| VBD
multiple  ||| S:988 E:997 ||| JJ
tumors  ||| S:997 E:1004 ||| NNS
in  ||| S:1004 E:1007 ||| IN
the  ||| S:1007 E:1011 ||| DT
right  ||| S:1011 E:1017 ||| JJ
ureter ||| S:1017 E:1023 ||| NN
,  ||| S:1023 E:1025 ||| ,
and  ||| S:1025 E:1029 ||| CC
the  ||| S:1029 E:1033 ||| DT
distal  ||| S:1033 E:1040 ||| JJ
lesion  ||| S:1040 E:1047 ||| NNS
projecting  ||| S:1047 E:1058 ||| VBG
into  ||| S:1058 E:1063 ||| IN
the  ||| S:1063 E:1067 ||| DT
bladder ||| S:1067 E:1074 ||| NN
.  ||| S:1074 E:1076 ||| .
After  ||| S:1076 E:1082 ||| IN
the  ||| S:1082 E:1086 ||| DT
general  ||| S:1086 E:1094 ||| JJ
condition  ||| S:1094 E:1104 ||| NN
became  ||| S:1104 E:1111 ||| VBD
well  ||| S:1111 E:1116 ||| RB
by  ||| S:1116 E:1119 ||| IN
right  ||| S:1119 E:1125 ||| JJ
nephrostomy  ||| S:1125 E:1137 ||| NN
for  ||| S:1137 E:1141 ||| IN
infection  ||| S:1141 E:1151 ||| NN
control ||| S:1151 E:1158 ||| NN
,  ||| S:1158 E:1160 ||| ,
transurethral  ||| S:1160 E:1174 ||| JJ
resection  ||| S:1174 E:1184 ||| NN
of  ||| S:1184 E:1187 ||| IN
bladder  ||| S:1187 E:1195 ||| JJ
tumor  ||| S:1195 E:1201 ||| NN
was  ||| S:1201 E:1205 ||| VBD
performed ||| S:1205 E:1214 ||| VBN
.  ||| S:1214 E:1216 ||| .
Histological  ||| S:1216 E:1229 ||| JJ
examination  ||| S:1229 E:1241 ||| NN
of  ||| S:1241 E:1244 ||| IN
the  ||| S:1244 E:1248 ||| DT
specimen  ||| S:1248 E:1257 ||| FW
revealed  ||| S:1257 E:1266 ||| FW
a  ||| S:1266 E:1268 ||| FW
metastatic  ||| S:1268 E:1279 ||| FW
tubular  ||| S:1279 E:1287 ||| FW
adenocarcinoma  ||| S:1287 E:1302 ||| FW
( ||| S:1302 E:1303 ||| -LRB-
colon  ||| S:1303 E:1309 ||| NN
origin ||| S:1309 E:1315 ||| NN
) ||| S:1315 E:1316 ||| -RRB-
.  ||| S:1316 E:1318 ||| .
Although  ||| S:1318 E:1327 ||| IN
right  ||| S:1327 E:1333 ||| JJ
nephrectomy  ||| S:1333 E:1345 ||| NN
was  ||| S:1345 E:1349 ||| VBD
performed  ||| S:1349 E:1359 ||| VBN
for  ||| S:1359 E:1363 ||| IN
pyonephrosis  ||| S:1363 E:1376 ||| JJ
control ||| S:1376 E:1383 ||| NN
,  ||| S:1383 E:1385 ||| ,
she  ||| S:1385 E:1389 ||| PRP
died  ||| S:1389 E:1394 ||| VBD
of  ||| S:1394 E:1397 ||| IN
local  ||| S:1397 E:1403 ||| JJ
progression  ||| S:1403 E:1415 ||| NN
of  ||| S:1415 E:1418 ||| IN
ascending  ||| S:1418 E:1428 ||| VBG
colon  ||| S:1428 E:1434 ||| NN
cancer  ||| S:1434 E:1441 ||| NN
10  ||| S:1441 E:1444 ||| CD
months  ||| S:1444 E:1451 ||| NNS
after  ||| S:1451 E:1457 ||| IN
first  ||| S:1457 E:1463 ||| JJ
visit ||| S:1463 E:1468 ||| NN
.  ||| S:1468 E:1470 ||| .
Intraluminal  ||| S:1470 E:1483 ||| JJ
ureteral  ||| S:1483 E:1492 ||| JJ
progression  ||| S:1492 E:1504 ||| NN
of  ||| S:1504 E:1507 ||| IN
carcinoma  ||| S:1507 E:1517 ||| JJ
originating  ||| S:1517 E:1529 ||| NN
from  ||| S:1529 E:1534 ||| IN
organs  ||| S:1534 E:1541 ||| JJ
other  ||| S:1541 E:1547 ||| JJ
than  ||| S:1547 E:1552 ||| IN
urinary  ||| S:1552 E:1560 ||| JJ
tract  ||| S:1560 E:1566 ||| NN
is  ||| S:1566 E:1569 ||| VBZ
very  ||| S:1569 E:1574 ||| RB
rare ||| S:1574 E:1578 ||| JJ
.  ||| S:1578 E:1580 ||| .
To  ||| S:1580 E:1583 ||| TO
our  ||| S:1583 E:1587 ||| PRP$
knowledge ||| S:1587 E:1596 ||| NN
,  ||| S:1596 E:1598 ||| ,
this  ||| S:1598 E:1603 ||| DT
is  ||| S:1603 E:1606 ||| VBZ
the  ||| S:1606 E:1610 ||| DT
9th  ||| S:1610 E:1614 ||| JJ
report  ||| S:1614 E:1621 ||| NN
in  ||| S:1621 E:1624 ||| IN
the  ||| S:1624 E:1628 ||| DT
English  ||| S:1628 E:1636 ||| NNP
or  ||| S:1636 E:1639 ||| CC
Japanese  ||| S:1639 E:1648 ||| JJ
literature ||| S:1648 E:1658 ||| NN
.  ||| S:1658 E:1660 ||| .
In  ||| S:1660 E:1663 ||| IN
this  ||| S:1663 E:1668 ||| DT
case  ||| S:1668 E:1673 ||| NN
we  ||| S:1673 E:1676 ||| PRP
could  ||| S:1676 E:1682 ||| MD
not  ||| S:1682 E:1686 ||| RB
rule  ||| S:1686 E:1691 ||| VB
out  ||| S:1691 E:1695 ||| RP
primary  ||| S:1695 E:1703 ||| JJ
ureteral  ||| S:1703 E:1712 ||| JJ
cancer  ||| S:1712 E:1719 ||| NN
preoperatively ||| S:1719 E:1733 ||| NN
,  ||| S:1733 E:1735 ||| ,
and  ||| S:1735 E:1739 ||| CC
histological  ||| S:1739 E:1752 ||| JJ
examination  ||| S:1752 E:1764 ||| NN
revealed  ||| S:1764 E:1773 ||| VBD
intraluminal  ||| S:1773 E:1786 ||| JJ
ureteral  ||| S:1786 E:1795 ||| JJ
dissemination  ||| S:1795 E:1809 ||| NN
of  ||| S:1809 E:1812 ||| IN
ascending  ||| S:1812 E:1822 ||| VBG
colon  ||| S:1822 E:1828 ||| NN
cancer ||| S:1828 E:1834 ||| NN
.  ||| S:1834 E:1836 ||| .
